Douglas Mcneel, M.d., Ph.d.

Biography

 Dr. McNeel is Professor of Medicine at the University of Wisconsin, Madison. He is a genitourinary medical oncologist with a research laboratory and clinical research program that has focused on prostate cancer immunology for two decades.The long-term goal of Dr. McNeel’s research efforts is to develop effective anti-tumor vaccines as treatments for prostate cancer. His current research efforts seek to identify immunologically recognized proteins of the prostate, characterize these as tumor target antigens, and evaluate anti-tumor genetic vaccines targeting these antigens in appropriate pre-clinical models. Dr. McNeel is specifically evaluating plasmid DNA vaccines encoding these antigens, and is actively translating these findings in early phase human clinical trials.Dr. McNeel has authored more than 100 publications, multiple issued patents covering the prostatic acid phosphatase and androgen receptor plasmid DNA vaccines, as well as several pending patents.His work provides the underpinning scientific and clinical innovation for MVI.

Research Interest

 Oncology, DNA Vaccine